In NAFLD development, the activities of key regulators such as AMPK, SREBP-1c, PPAR-γ, and TNF-α are interconnected in a way that collectively disrupts hepatic lipid homeostasis [6, 7]. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.